# REC Core

> **NIH NIH P30** · WAKE FOREST UNIVERSITY HEALTH SCIENCES · 2024 · $107,861

## Abstract

Research Education Component – Project Summary
The Research Education Component will collaborate with other ADRC Cores and affiliate members to provide
critical training and education to build a pipeline of new investigators from diverse backgrounds and with the
necessary research interests and skills to meaningfully contribute to ADRD research – particularly with regard
to metabolic and vascular risk factors underlying ADRD pathogenesis. In the last 4 years, we supported
training of 20 graduate students and 8 postdoctoral fellows, and intensive mentoring for 17 junior faculty – 70%
of whom now serve as Principal Investigators on 22 NIH or foundation ADRD grants. In the next cycle, REC
programs will continue to leverage unique strengths and resources of the institution and the ADRC, particularly
with regard to our experiences conducting ADRD translational research – from cellular mechanisms through
rodent and nonhuman primate models to large-scale multi-site clinical studies. The REC Scholars Program will
provide individualized and comprehensive training to junior investigators with clinical or basic science expertise
to facilitate expansion of their work to support key concepts in translational science that could be instrumental
in identifying effective strategies for ADRD prevention and treatment. The REC will also develop and deliver an
extensive portfolio of ADRD-related educational programming for undergraduates, graduate students, fellows,
and investigators from other disciplines to further expand the new investigator pipeline through ADRC
interactions with Pepper OAIC, CTSI and other institutional programs. Given Wake Forest’s well-known and
successful history conducting large multi-site clinical studies in older adults, a focus of the REC training
program will include Team Science to provide new investigators with the skills to ensure successful project
management, development of strong and sustainable collaborations, and effective leadership of
multidisciplinary teams. Such teams will be essential for scientific discovery targeting prevention and treatment
of ADRDs, which are characteristically heterogeneous in clinical presentation, etiology, and pathologic
trajectory.

## Key facts

- **NIH application ID:** 10874743
- **Project number:** 5P30AG072947-04
- **Recipient organization:** WAKE FOREST UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Laura D. Baker
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $107,861
- **Award type:** 5
- **Project period:** 2021-08-15 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10874743

## Citation

> US National Institutes of Health, RePORTER application 10874743, REC Core (5P30AG072947-04). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10874743. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*